Sanofi
Tracked across 22 events · 171 articles · First seen Dec 05, 2025 · Last active Jul 06, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Sanofi announced positive Phase 2 clinical trial results for its drug lunsekimig in respiratory diseases, which could lead to new treatment options and future revenue streams.
Apr 07, 2026 · 6 articles
Business
Impact: Sanofi, in collaboration with Regeneron Pharmaceuticals, developed Dupixent and received International — European Commission approval for its use in treating chronic spontaneous urticaria in young children, which is expected to boost its market position and revenue.
Apr 13, 2026 · 8 articles
Business
Impact: Sanofi is extending its commitment to improving lives beyond healthcare through its foundation's strengthened focus on children and young people, which could enhance its corporate social responsibility image.
Jun 25, 2026 · 6 articles
Regulatory
Impact: Sanofi is under formal antitrust investigation by the International — European Commission for allegedly disparaging a rival flu vaccine, which could lead to penalties and reputational damage.
Jun 26, 2026 · 6 articles
Domestic
Impact: Sanofi is a major insulin maker that has moved to cut the cost of insulin and offers a savings program for people without health insurance.
Apr 02, 2026 · 6 articles
Domestic
Impact: Sanofi, a hepatitis B vaccine maker, defended its products as safe, and its U.S.-listed shares ended up 1.3%.
Dec 05, 2025 · 7 articles
Tech
Impact: Sanofi is an early adopter of YesWeHack's Agentic Pentest, suggesting a proactive approach to enhancing their cybersecurity defenses.
Jun 25, 2026 · 6 articles
Tech
Impact: Sanofi is a sponsor of World Hemophilia Day 2026, supporting the World Federation of Hemophilia's efforts.
Apr 17, 2026 · 6 articles
Business
Impact: Sanofi is a partner of Orano in developing targeted alpha therapies, indicating potential future collaboration and market opportunities in cancer treatment.
Jul 01, 2026 · 6 articles
Regulatory
Impact: Sanofi is mentioned as a collaborator with Innate Pharma in immuno-oncology.
Apr 02, 2026 · 7 articles
Business
Impact: Sanofi is mentioned as a collaborator with Innate Pharma, indicating existing partnerships in immuno-oncology.
Apr 08, 2026 · 6 articles
Business
Impact: Ingrid Müller held senior international leadership roles at Sanofi prior to joining Evotec.
Apr 15, 2026 · 7 articles
Business
Impact: Sanofi acquired Blueprint Medicines Corp., a company where Dr. Lynn Seely previously served as a lead independent director.
Apr 20, 2026 · 6 articles
Business
Impact: Dieter Weinand has led business operations for companies including Sanofi.
Apr 07, 2026 · 9 articles
Regulatory
Impact: Sanofi is mentioned as a biopharmaceutical company with whom Innate Pharma has established collaborations.
Apr 13, 2026 · 6 articles
100
International — European Commission opened investigation SanofiEU probes Sanofi flu vaccine
90
Sanofi promoted vaccine CSL Limited — CSL LimitedEU probes Sanofi flu vaccine
ERGEN INTELLIGENCE
Track Sanofi live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard